Results 81 to 90 of about 696,855 (303)

Chinese and western medicine treatment of myocardial fibrosis drugs

open access: yesFrontiers in Cardiovascular Medicine
Myocardial fibrosis (MF) is a common pathological manifestation of many cardiovascular diseases, such as myocardial infarction, myocardial ischemia, and sudden cardiac death.
Yuxi Zhu   +7 more
doaj   +1 more source

Myocardial fibrosis during atrial fibrillation: histological and cardiographic predictors

open access: yesИзвестия высших учебных заведений. Поволжский регион: Медицинские науки, 2023
Background. The formation of myocardial fibrosis is the leading mechanism for occurrence of atrial fibrillation (AF). In this regard, an attempt to prevent development of myocardial fibrosis and its treatment is pathogenetically expedient.
R.F. Rakhmatullov   +2 more
doaj   +1 more source

How do adults with cystic fibrosis cope following a diagnosis of diabetes? [PDF]

open access: yes, 2008
The official published version of the article can be obtained from the link below.Aim. This paper is a report of a study examining the experience of adults with cystic fibrosis in adapting to the diagnosis of diabetes, a second chronic illness ...
Reynolds, F, Collins, S
core   +1 more source

Celastrol‐Loaded Conductive Hydrogel Mitigates Myocardial Ischemia‐Reperfusion Injury and Restores Electrophysiological Function

open access: yesAdvanced Science, EarlyView.
Schematic illustration of the Pluronic F127 diacrylate/gelatin methacryloyl/poly(3,4‐ethylenedioxythiophene):poly(styrenesulfonate)/celastrol hydrogel (FGPC) for localized myocardial ischemia–reperfusion injury treatment. FGPC combines sustained celastrol delivery with PEDOT:PSS‐mediated conductive support to attenuate acute oxidative/inflammatory ...
Shixin Wang   +10 more
wiley   +1 more source

Myocardial fibrosis in hypertrophic cardiomyopathy [PDF]

open access: yes, 2018
Hypertrophic cardiomyopathy (HCM) is characterised by myocardial hypertrophy, fibrosis and abnormal vascular pathology and is usually caused by mutations in sarcomeric protein genes.
Patel, Vimal
core   +1 more source

Intermittent Fasting Restores Cardiac Lipid Homeostasis in Diabetic Cardiomyopathy in Association With Akkermansia Muciniphila and 1‐methyl‐L‐histidine

open access: yesAdvanced Science, EarlyView.
Intermittent fasting reshapes the gut microbiota in diabetic cardiomyopathy, restoring Akkermansia muciniphila and the microbiota‐associated metabolite 1‐methyl‐L‐histidine. This shift is linked to improved cardiac lipid homeostasis, reduced lipid peroxidation, and attenuated myocardial injury, highlighting a gut microbiota–metabolite–lipid axis in ...
Kaiyuan Jiang   +7 more
wiley   +1 more source

Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis

open access: yesFrontiers in Pharmacology
Cardiovascular diseases have become the leading cause of death in urban and rural areas. Myocardial fibrosis is a common pathological manifestation at the adaptive and repair stage of cardiovascular diseases, easily predisposing to cardiac death.
Minghui Wang   +12 more
doaj   +1 more source

Characterization of the Early Cellular Mechanisms Promoting Myocardial Fibrosis

open access: yes, 2012
Myocardial fibrosis is a common pathological finding in patients with cardiovascular disease and is believed to be a major contributing factor in the development of end stage organ failure.
Sopel, Mryanda
core  

PEAR1 Promotes Glucose Metabolism Reprogramming in Sepsis‐Associated Acute Lung Injury via AARS1‐Mediated HIF‐1α Lactylation

open access: yesAdvanced Science, EarlyView.
This study revealed that a PEAR1/HIF‐1α/ glycolysis/lactate/H3K18la positive feedback loop in PMVECs that drives the development of S‐ALI. Mechanistically, PEAR1 mediates the binding of HIF‐1α to AARS1, leading to the lactylation of HIF‐1α, the primary lactylation site of which is K172.
Shuai Li   +15 more
wiley   +1 more source

How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy

open access: yesAnnals of Noninvasive Electrocardiology, 2020
Background Structural myocardial changes in hypertrophic cardiomyopathy (HCM) are associated with different abnormalities on electrocardiographs (ECGs). The diagnostic value of the ECG voltage criteria used to screen for left ventricular hypertrophy (LVH)
Zsofia Dohy   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy